about
Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytesImplications of the serine protease HtrA1 in amyloid precursor protein processingEsterified eicosanoids are acutely generated by 5-lipoxygenase in primary human neutrophils and in human and murine infectionMacrophage heterogeneity and acute inflammationTherapeutic strategies for the clinical blockade of IL-6/gp130 signalingSTAT3 acts as a co-activator of glucocorticoid receptor signalingThe role of human HtrA1 in arthritic diseaseInterplay between IFN-gamma and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammationParacetamol reduces influenza-induced immunopathology in a mouse model of infection without compromising virus clearance or the generation of protective immunityPhosphatidylethanolamine-esterified eicosanoids in the mouse: tissue localization and inflammation-dependent formation in Th-2 disease.IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation.Interferon-gamma inhibits interleukin-1beta-induced matrix metalloproteinase production by synovial fibroblasts and protects articular cartilage in early arthritis.Differential dependencies of monocytes and neutrophils on dectin-1, dectin-2 and complement for the recognition of fungal particles in inflammationDirecting transition from innate to acquired immunity: defining a role for IL-6.The response of interleukin-6 and soluble interleukin-6 receptor isoforms following intermittent high intensity and continuous moderate intensity cyclingA role for IL-27p28 as an antagonist of gp130-mediated signaling.LAB/NTAL facilitates fungal/PAMP-induced IL-12 and IFN-γ production by repressing β-catenin activation in dendritic cellsTherapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritis.The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R/IL-6 complex.Regulatory B cells are induced by gut microbiota-driven interleukin-1β and interleukin-6 production.Classic interleukin-6 receptor signaling and interleukin-6 trans-signaling differentially control angiotensin II-dependent hypertension, cardiac signal transducer and activator of transcription-3 activation, and vascular hypertrophy in vivo.IL-6 transsignaling: the in vivo consequences.Cytomegalovirus-Specific IL-10-Producing CD4+ T Cells Are Governed by Type-I IFN-Induced IL-27 and Promote Virus Persistence.Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer.Circulating neutrophils maintain physiological blood pressure by suppressing bacteria and IFNgamma-dependent iNOS expression in the vasculature of healthy mice.IL-10 differentially controls the infiltration of inflammatory macrophages and antigen-presenting cells during inflammation.Distinct bone marrow-derived and tissue-resident macrophage lineages proliferate at key stages during inflammation.Interleukin-6 limits influenza-induced inflammation and protects against fatal lung pathology.Interleukin-6 signaling drives fibrosis in unresolved inflammation.Myeloid 12/15-LOX regulates B cell numbers and innate immune antibody levels in vivo.Neutrophils recruited by IL-22 in peripheral tissues function as TRAIL-dependent antiviral effectors against MCMV.The problem of choice: current biologic agents and future prospects in RA.IL-6 as a keystone cytokine in health and disease.The antiviral restriction factor IFN-induced transmembrane protein 3 prevents cytokine-driven CMV pathogenesis.On-going Mechanical Damage from Mastication Drives Homeostatic Th17 Cell Responses at the Oral BarrierInhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptorIn vivo functional analysis and genetic modification of in vitro-derived mouse neutrophils.Hoxb8 conditionally immortalised macrophage lines model inflammatory monocytic cells with important similarity to dendritic cells.Transgenic blockade of interleukin 6 transsignaling abrogates inflammation.IL-6 Trans-Signaling Links Inflammation with Angiogenesis in the Peritoneal Membrane.
P50
Q24336187-56D252DE-794B-4349-B0AB-6466E3D6E29FQ24523725-86482914-1E2F-4CB9-8E9D-BB4140E74DFAQ24604441-0C12B4BF-63E6-4D72-8050-5270062A70E6Q26996732-5AAD070E-3C88-4972-A1D7-9922AA464AAAQ27002391-4CEBED73-CB66-42EA-94AB-C1D5A435F363Q28255683-5C029CA4-6364-4952-831D-E60A31CA5756Q28288792-BCF5D037-B4D4-4D58-A0BE-BFF7F89B3B22Q28589039-E9B7425C-86EA-42A2-B0C4-7E4ACFD0B657Q30399547-9D4F5456-7716-424C-813E-D31789239B48Q33468762-3E8F1F95-B7F0-4665-B661-673D0CC0A482Q33892268-1963F8D5-8B1C-40FC-B3B9-70CDE21F9C4DQ33923325-6B632367-09C5-4FE2-B6E8-3B35F5313EEDQ34438395-2C701FD8-7F19-4F5D-B320-ACE701D5DE58Q34449051-16A20C80-874D-4F0D-A600-67558C2D573EQ34505786-DE2052CB-2987-42ED-8EBA-20C99BB35D50Q34688139-8B3BFDC9-14C7-48AB-8786-6E224BD58971Q34722541-91264AF0-880F-488D-9D04-33FCB6514A1AQ34910849-30C86B1F-B0C6-4B58-A368-43BE0E793596Q34991808-D0989555-2584-4996-8E37-1D11EF676DA7Q35345421-9EBACC3A-8B99-4CC7-A454-F16DB40F8844Q35928298-673E5315-8FE8-4A20-9E75-4A3C717D1074Q36116485-C019602A-2AA7-419F-9DC2-F9E690D3D550Q36214992-ABB868E0-FF37-4A44-ADB3-299658012788Q36481367-6AE861A1-8F14-42F2-8799-7CF2A14D8D26Q37014315-588CF68F-3BC2-4231-9E42-648B9868C8BAQ37261611-DD71457E-C8EB-4A73-B487-0B719C7CEEA2Q37346583-DD97A98E-CE7A-47F3-9B92-DACF57750E22Q37455968-797C4837-148E-434B-8C51-1494B0CBBCE7Q37572817-E1A8A710-0BC9-4AC3-B315-7EB5EF263C60Q37660098-81DEBDC7-F373-4D09-A9FA-3CBC0CBEFE32Q37706595-D65D9BC3-50CB-4F5C-8D16-AA4E85592164Q38082588-17C1D616-73BB-42E4-88B9-1F29A60F86C9Q38433045-3E029E0B-A932-451F-83A3-707F07A46285Q38940024-72863C10-8F53-46CD-A4C7-1F46D7FCF8DFQ39021405-CC70F03E-C107-4CFD-828C-E17A0556C8B1Q39459586-38B64522-EA9A-44C6-AB21-391331CC7CEBQ39582887-C8EAF3AC-D64F-4BC1-AB16-D15F0EA15A14Q39602540-1651F927-5B8D-4146-AE75-62563B56B6BAQ40055031-ED4BD6D8-981A-45BF-8824-61A45C33552EQ40455037-509C35EE-5BB5-40D9-B7DB-9D499442D474
P50
description
researcher ORCID ID = 0000-0001-7297-9711
@en
wetenschapper
@nl
name
Simon A Jones
@ast
Simon A Jones
@en
Simon A Jones
@es
Simon A Jones
@nl
type
label
Simon A Jones
@ast
Simon A Jones
@en
Simon A Jones
@es
Simon A Jones
@nl
prefLabel
Simon A Jones
@ast
Simon A Jones
@en
Simon A Jones
@es
Simon A Jones
@nl
P1153
7405936345
P21
P31
P496
0000-0001-7297-9711